Synergistic Anti-Microbial Coating Systems for Prosthetic Implants

Publication ID: 24-11857695_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Anti-Microbial Coating Systems for Prosthetic Implants,” Published Technical Disclosure No. 24-11857695_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857695_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,695.

Summary of the Inventive Concept

The present invention integrates anti-microbial coatings with AI, IoT, blockchain, and genomics to create a powerful system for monitoring, controlling, and optimizing coating performance on prosthetic implants, minimizing infection risks and enhancing patient outcomes.

Background and Problem Solved

The original patent disclosed an anti-microbial coating for objects such as prosthetic implants. However, it did not address the need for real-time monitoring, data-driven optimization, and secure patient data management. The present inventive concept solves this problem by synergistically combining the anti-microbial coating with cutting-edge technologies.

Detailed Description of the Inventive Concept

The system comprises an IoT-enabled sensor for detecting bacterial growth on the implant, an AI-powered analytics module for predicting the likelihood of infection, and a blockchain-based data storage module for securely recording patient data and coating performance. The system can be integrated with machine learning algorithms to optimize coating formulations, and with genomics analysis to generate personalized coatings. The inventive concept enables real-time monitoring, data-driven decision-making, and secure data management, thereby minimizing infection risks and enhancing patient outcomes.

Novelty and Inventive Step

The new claims introduce the innovative integration of AI, IoT, blockchain, and genomics with anti-microbial coatings, providing a synergistic system that is not obvious from the original patent. The inventive concept's novelty lies in its ability to monitor, control, and optimize coating performance in real-time, ensuring a higher level of patient safety and outcomes.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different AI algorithms, IoT sensor configurations, or blockchain platforms. Variations may involve integrating the system with other medical devices or incorporating additional data sources, such as electronic health records or wearables.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the orthopedic and prosthetic implant markets. The system's ability to minimize infection risks and enhance patient outcomes can lead to increased adoption and market share. Additionally, the system's data-driven approach can generate new revenue streams through data analytics and services.

CPC Classifications

SectionClassGroup
A A61 A61L27/303
A A61 A61L27/06
A A61 A61L27/54
A A61 A61L2300/404
A A61 A61L2400/18

Field of Art

Medical device engineering, specifically anti-microbial coating technologies for prosthetic implants, requiring expertise in surface modification, plasma treatment, materials science, and biomedical engineering

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or materials scientist with advanced degree, experience in surface modification techniques, understanding of plasma deposition, microbial interaction with medical surfaces, and familiarity with emerging digital health technologies

Obviousness Rationale

A PHOSITA would recognize that integrating digital monitoring technologies with established anti-microbial coating techniques represents a predictable extension of existing medical device innovation. The combination of IoT sensors, AI analytics, and blockchain tracking with known plasma-based surface modification represents an incremental technological advancement using standard engineering design approaches. The core anti-microbial coating methodology remains fundamentally consistent with the source patent's teachings, with digital technologies providing enhanced performance monitoring and optimization.

Obvious Combinations & Variations

Source Patent Element
Plasma-enhanced chemical vapor deposition for creating oxygen-based functional groups on medical implant surfaces
PTD Variation
Adding IoT-enabled sensors to monitor bacterial growth and coating performance in real-time
Obviousness Reasoning
Integrating sensor technologies to monitor surface treatments is a known technique in medical device engineering, representing a predictable application of existing monitoring capabilities
Source Patent Element
Anti-microbial coating method for prosthetic implants
PTD Variation
Implementing machine learning algorithms to optimize coating formulations based on bacterial growth patterns
Obviousness Reasoning
Using computational methods to analyze and improve medical device performance is a standard engineering approach with well-established methodological precedents
Source Patent Element
Surface treatment of metallic medical implants
PTD Variation
Incorporating genomics analysis to generate personalized anti-microbial coating configurations
Obviousness Reasoning
Personalization of medical technologies through genetic profiling represents a logical extension of existing precision medicine approaches
Source Patent Element
Plasma-based surface modification for medical implants
PTD Variation
Blockchain-based tracking and verification of coating performance and patient data
Obviousness Reasoning
Implementing secure, distributed record-keeping for medical device performance is a predictable technological evolution in digital health infrastructure
Source Patent Element
Anti-microbial coating methodology for prosthetic implants
PTD Variation
AI-powered analytics module for predicting infection likelihood
Obviousness Reasoning
Applying predictive analytics to medical device performance monitoring represents a standard approach in contemporary biomedical engineering
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857695 and the present published technical disclosure, a person having ordinary skill in the art would find the integration of digital monitoring technologies with established anti-microbial coating methodologies to be an obvious technological progression, rendering potential patent claims covering such combinations anticipated and non-patentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,695
TitleAnti-microbial coating for objects such as prosthetic implants
Assignee(s)National University of Ireland, Galway